BRNS
Barinthus Biotherapeutics plc.
0.00 (0.00%)0.74USD0成交股數30.2M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 | 09-09 | DAWES KAREN A | Director | D 處分 | 1.7K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Enright William | Chief Executive Officer | D 處分 | 728K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Enright William | Chief Executive Officer | D 處分 | 515K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Hammacher Alex | Director | D 處分 | 3.0K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Hooftman Leon | Chief Medical Officer | A 獲配股票 | 362K | – | – | 362K | SEC |
| 2026-09-09 | 09-09 | Hooftman Leon | Chief Medical Officer | D 處分 | 362K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Morgon Pierre A. | Director | D 處分 | 10.5K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Phillips Anne M. | Director | D 處分 | 3.0K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Scheeren Joseph | Director | D 處分 | 23.0K | – | – | 0 | SEC |
| 2026-09-09 | 09-09 | Wright Robin | Director | D 處分 | 48.3K | – | – | 0 | SEC |
| 2023-06-26 | 06-28 | Scheeren Joseph | Director | P 公開市場買進 | 10.0K | 2.44 | 24K | 23.0K | SEC |
| 2023-05-25 | 06-01 | Wright Robin | Director | P 公開市場買進 | 13.8K | 2.66 | 37K | 48.3K | SEC |
| 2023-03-27 | 03-29 | Enright William | Chief Executive Officer | S 公開市場賣出 | 15.0K | 2.42 | 36K | 728K | SEC |
| 2022-09-30 | 10-04 | M&G INVESTMENT MANAGEMENT LTD | TenPercentOwner | J 其他 | 4.1M | – | – | 5.2M | SEC |
| 2022-09-30 | 10-04 | M&G Alternatives Investment Management Ltd | TenPercentOwner | J 其他 | 4.1M | – | – | 0 | SEC |
| 2022-08-25 | 08-26 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 25.0K | 7.07 | 177K | 75 | SEC |
| 2022-08-25 | 08-26 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 10.0K | 7.39 | 74K | 104K | SEC |
| 2022-08-25 | 08-26 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 39.2K | – | – | 39.3K | SEC |
| 2022-08-25 | 08-26 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 14.2K | 5.69 | 81K | 25.1K | SEC |
| 2022-08-24 | 08-26 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 450 | – | – | 525 | SEC |
| 2022-08-24 | 08-26 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 450 | 4.78 | 2K | 75 | SEC |
| 2022-08-18 | 08-19 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 2.2K | – | – | 2.3K | SEC |
| 2022-08-18 | 08-19 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 2.2K | 4.84 | 11K | 75 | SEC |
| 2022-08-17 | 08-19 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 500 | 4.76 | 2K | 114K | SEC |
| 2022-08-17 | 08-19 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 649 | – | – | 724 | SEC |
| 2022-08-17 | 08-19 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 649 | 4.77 | 3K | 75 | SEC |
| 2022-08-16 | 08-17 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 2.2K | – | – | 2.3K | SEC |
| 2022-08-16 | 08-17 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 1.2K | 4.82 | 6K | 115K | SEC |
| 2022-08-16 | 08-17 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 2.2K | 4.78 | 11K | 75 | SEC |
| 2022-08-15 | 08-17 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 5.3K | 4.76 | 25K | 75 | SEC |
| 2022-08-15 | 08-17 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 2.4K | 4.75 | 11K | 116K | SEC |
| 2022-08-15 | 08-17 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 5.3K | – | – | 5.4K | SEC |
| 2022-08-12 | 08-15 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 5.0K | 4.50 | 23K | 118K | SEC |
| 2022-06-28 | 07-15 | Ellis Christopher | Chief Operating Officer | M 選擇權執行 | 5 | – | – | 80 | SEC |
| 2022-06-28 | 07-15 | Ellis Christopher | Chief Operating Officer | S 公開市場賣出 | 5 | 6.00 | 30.00 | 75 | SEC |
| 2022-06-23 | 07-15 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 1.9K | – | – | 118K | SEC |
| 2022-06-23 | 07-15 | Griffiths Graham | Chief Business Officer | S 公開市場賣出 | 8 | 5.28 | 42.24 | 123K | SEC |
| 2022-06-23 | 07-15 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 3.1K | – | – | 123K | SEC |
| 2022-06-23 | 07-15 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 2.3K | – | – | 120K | SEC |
| 2022-04-01 | 04-04 | Scheeren Joseph | Director | P 公開市場買進 | 10.0K | 5.09 | 51K | 13.0K | SEC |
| 2022-03-31 | 04-04 | Hammacher Alex | Director | P 公開市場買進 | 2.0K | 5.14 | 10K | 3.0K | SEC |
| 2021-12-31 | 01-04 | Hammacher Alex | Director | P 公開市場買進 | 1.0K | 10.86 | 11K | 1.0K | SEC |
| 2021-12-22 | 12-23 | Wright Robin | Director | P 公開市場買進 | 10.0K | 9.97 | 100K | 34.5K | SEC |
| 2021-12-17 | 02-11 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 3.1K | – | – | 116K | SEC |
| 2021-12-17 | 02-11 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 5.8K | – | – | 108K | SEC |
| 2021-12-17 | 02-11 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 102K | – | – | 102K | SEC |
| 2021-12-17 | 02-11 | Griffiths Graham | Chief Business Officer | M 選擇權執行 | 4.6K | – | – | 113K | SEC |
| 2021-05-04 | 05-07 | Enright William | Chief Executive Officer | A 獲配股票 | 515K | – | – | 1.3M | SEC |
| 2021-05-04 | 05-06 | Scheeren Joseph | Director | P 公開市場買進 | 3.0K | 17.00 | 51K | 3.0K | SEC |
| 2021-05-04 | 05-06 | Ellis Christopher | Chief Operating Officer | P 公開市場買進 | 75 | 17.00 | 1K | 75 | SEC |
| 2021-05-04 | 05-06 | Wright Robin | Director | P 公開市場買進 | 14.0K | 17.00 | 238K | 24.5K | SEC |
| 2021-05-04 | 05-06 | Griffiths Graham | Chief Business Officer | P 公開市場買進 | 100 | 17.00 | 2K | 100 | SEC |
| 2021-05-04 | 05-06 | DAWES KAREN A | Director | P 公開市場買進 | 1.7K | 17.00 | 29K | 1.7K | SEC |
| 2021-05-04 | 05-06 | Oxford Sciences Innovation plc | TenPercentOwner | P 公開市場買進 | 600K | 17.00 | 10.2M | 8.8M | SEC |
| 2021-05-04 | 05-06 | Oxford Sciences Innovation plc | TenPercentOwner | C 轉換 | 4.8M | – | – | 4.8M | SEC |
| 2021-05-04 | 05-06 | Oxford Sciences Innovation plc | TenPercentOwner | C 轉換 | 1.7M | – | – | 6.5M | SEC |
| 2021-05-04 | 05-06 | Oxford Sciences Innovation plc | TenPercentOwner | C 轉換 | 1.7M | – | – | 8.2M | SEC |
| 2021-05-04 | 05-06 | Phillips Anne M. | Director | P 公開市場買進 | 3.0K | 17.00 | 51K | 3.0K | SEC |
| 2021-04-30 | 05-03 | M&G INVESTMENT MANAGEMENT LTD | TenPercentOwner | P 公開市場買進 | 125K | 14.40 | 1.8M | 1.1M | SEC |
| 2021-04-29 | 05-04 | Enright William | Chief Executive Officer | A 獲配股票 | 456K | – | – | 1.2M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| M&G PLC | 5.2M | 5.2M | 不變 | 持平 |
| HSG Holding Ltd | 1.4M | 938K | 不變 | 持平 |
| GLR Partners, LLC | 1.2M | 821K | 不變 | 持平 |
| DC Funds, LP | 642K | 424K | 不變 | 持平 |
| Rangeley Capital, LLC | 185K | 122K | +25.7K (+16%) | 加碼 |
| Johns Hopkins University | 122K | 81K | 不變 | 持平 |
| MORGAN STANLEY | 109K | 72K | +107K (+4825%) | 加碼 |
| Baird Financial Group, Inc. | 106K | 70K | 不變 | 持平 |
| 城堡 CITADEL ADVISORS LLC | 76.8K | 51K | −42.2K (-35%) | 減碼 |
| HighTower Advisors, LLC | 37.5K | 25K | 不變 | 持平 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 25.0K | 17K | −126K (-83%) | 減碼 |
| XTX Topco Ltd | 14.8K | 10K | 新進 | 新進 |
| RHUMBLINE ADVISERS | 11.7K | 8K | 不變 | 持平 |
| TWO SIGMA SECURITIES, LLC | 11.1K | 7K | 新進 | 新進 |
| UBS Group AG | 1.0K | 665.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 15 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 3 / 2 / 2 / 2 |
| 機構合計持股 · 佔流通股 | 9.2M · 22.5% |
| 合計季末市值 | 7.8M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 13.2K |
|---|---|
| 與上期比 | +46.2% |
| 佔流通股數 | 0.03% |
| 日均成交量 | 51.3K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 13.2K | +46.2% | 0.03% | 51.3K | 1.0 |
| 2026-08-14 | 9.0K | -80.3% | 0.02% | 42.2K | 1.0 |
| 2026-07-31 | 45.9K | +55.9% | 0.11% | 25.3K | 1.8 |
| 2026-07-15 | 29.4K | -34.2% | 0.07% | 59.1K | 1.0 |
| 2026-06-30 | 44.7K | +102.3% | 0.11% | 25.8K | 1.7 |
| 2026-06-15 | 22.1K | +575.0% | 0.05% | 264K | 1.0 |
| 2026-05-29 | 3.3K | -77.2% | 0.01% | 21.6K | 1.0 |
| 2026-05-15 | 14.3K | +85.2% | 0.04% | 20.1K | 1.0 |
| 2026-04-30 | 7.7K | -6.0% | 0.02% | 18.7K | 1.0 |
| 2026-04-15 | 8.2K | -21.3% | 0.02% | 18.3K | 1.0 |
| 2026-03-31 | 10.5K | +101.0% | 0.03% | 46.2K | 1.0 |
| 2026-03-13 | 5.2K | -35.2% | 0.01% | 17.6K | 1.0 |
| 2026-02-27 | 8.0K | +816.3% | 0.02% | 92.6K | 1.0 |
| 2026-02-13 | 877 | -38.8% | 0.00% | 50.9K | 1.0 |
| 2026-01-30 | 1.4K | -73.7% | 0.00% | 25.0K | 1.0 |
| 2026-01-15 | 5.4K | -27.2% | 0.01% | 56.8K | 1.0 |
| 2025-12-31 | 7.5K | +72.8% | 0.02% | 76.0K | 1.0 |
| 2025-12-15 | 4.3K | -52.4% | 0.01% | 79.7K | 1.0 |
| 2025-11-28 | 9.1K | -72.4% | 0.02% | 109K | 1.0 |
| 2025-11-14 | 32.9K | -19.1% | 0.08% | 179K | 1.0 |
| 2025-10-31 | 40.6K | +18.6% | 0.10% | 50.1K | 1.0 |
| 2025-10-15 | 34.3K | -72.2% | 0.08% | 165K | 1.0 |
| 2025-09-30 | 123K | +53.6% | 0.30% | 302K | 1.0 |
| 2025-09-15 | 80.2K | +496.7% | 0.20% | 62.7K | 1.3 |
| 2025-08-29 | 13.4K | +9.0% | 0.03% | 17.0K | 1.0 |
| 2025-08-15 | 12.3K | -70.4% | 0.03% | 42.7K | 1.0 |